Nanobiotix Shares Climb 7.04% This Morning
The French biotech company regains momentum on Tuesday morning at the Paris Stock Exchange, driven by a technical rebound after six consecutive sessions of decline.
Current Trading Session
The stock is up 7.04% this morning at 14.30 euros, briefly leaving the oppressive atmosphere of the past few days. However, this momentum only compensates for a tiny fraction of the past week's debacle: the stock is still down 34.7% over the last seven days, including a plunge of 17.12% on Monday alone. Trading remains moderate, with only 0.64% of the capital in circulation, indicating a lack of enthusiasm among investors. In a broader perspective, the stock is still buoyed by its previous performances: up 148.7% over three months and up 243.8% over a year, far exceeding the CAC 40's progress over the same period (up 9.82%), highlighting the high volatility characteristic of this sector. The Relative Strength Index positioned at 38 remains out of extreme zones and does not provide a clear signal at this time. The monthly volatility, measured at 40.88%, remains exceptional and reflects the wide oscillations that the stock typically displays.
Technical Analysis
From a technical standpoint, the stock is maintaining slightly above its 50-day moving average (13.35 euros), which provides it a small buffer against immediate downward pressures. However, the MACD histogram presents a mixed reading: it remains negative at -1.31, creating a divergence between the MACD line (1.09) and its signal line (2.40), suggesting a weakening of today's bullish movement. This configuration indicates a certain fragility in the ongoing recovery.
